Bluestem Biosciences closes $5 Million pre-seed funding

Bluestem Biosciences, a member of Bio Nebraska, announced a pre-seed financing round of $5 million that will be used to to scale discovery through industrial anaerobic fermentation.
Press Release from Bluestem Biosciences

Bluestem Biosciences, a renewable chemicals company maximizing agriculture and energy infrastructure through synthetic biology, announced a pre-seed financing round of $5 million. Zero Infinity Partners led the round including participation from Matt Vining, CEO of Navigator CO2 Ventures, Invest Nebraska, angel investor Robert Sali, and Bluestem Co-Founder & CEO Billy Hagstrom.

Founded in January 2022, Bluestem is focused on the sustainable bio-production of chemicals through anaerobic fermentation with an identified path toward industrial scale. Bluestem’s mission of diversifying and decarbonizing the chemical industry begins with purpose built biology for existing infrastructure.

“Bluestem’s approach on decarbonizing the petrochemical industry represents a large opportunity for Bluestem and our strategic partners,” said Billy Hagstrom. “Through our recent patent application and accomplishments year-to-date, Bluestem and our growing team are well positioned to transform infrastructure, beginning in the Midwest.”

The pre-seed funding will be used to build a leading team and product discovery pipeline powered by Bluestem’s proprietary digital biology architecture. This internally developed technology will allow Bluestem to accelerate discovery through an integration of existing and custom tools, focused on anaerobic bioproduction.

“Digital biology is a game-changer and foundational to Bluestem’s differentiated approach,” said Tyler Autera Co-Founder & Chief Technology Officer. “By leveraging these tools, Bluestem is augmenting discovery to accelerate science and our path to commercialization.”